Our Additional Services

Eye Scan with OCT Procedure for the Diagnosis of Optic Nerve Changes

OCT (Optical Coherence Tomography) is an examination using the latest laser technology. The eye scan is performed while sitting without medication or drops to dilate the pupils. In a few minutes, the retina is illuminated, and the images immediately provide information about the state of the optic nerves, which often show changes in the early stages of many neurological diseases.

MS-Fatigue – Eat, Move, and Breathe!

Multiple sclerosis is one of the most dynamically evolving neurological diseases with many exciting new research developments in this field. We now have a variety of different treatment approaches available, allowing us to offer patients a personalized therapy tailored to their individual needs and life situation.

As successful as disease control with medication may sometimes be, we also observe more and more other aspects that may affect a patient’s quality of life.  Fatigue e.g., is one of the most burdensome symptoms for many patients. It is also the most commonly complained about symptom, even ahead of impairments due to spasticity or bladder dysfunction. Diagnostically, we face the challenge of detecting a symptom that is hardly visible through traditional clinical tests. The impact of fatigue on quality of life is nevertheless demonstrably high.

As the leading MS center in Zurich, we want to guide our patients through the necessary diagnostic steps to help them decide on their individual therapy options. This requires a patient’s willingness and personal resilience to accept and continue with any necessary lifestyle changes. But perhaps this is precisely the difference from other symptoms of the disease that patients have no control over.

During this course, patients will learn whether and when medication makes sense, what role nutrition, gut flora, and exercise play, and how they can achieve success with even small daily changes.

  • Fatigue counseling sessions
  • In-depth sleep and fatigue diagnostics in our own sleep laboratory
  • Neuropsychological examination to better understand fatigue and to diagnose types of fatigue
  • Medication for extreme fatigue cases
  • Nutritional advice considering the microbiome and based on Ayurvedic principles
  • Exercise & breathing therapy
  • Acupuncture
Modular Patient Care

There have been significant advances in recent years in the treatment and care of people with multiple sclerosis, The significantly improved efficacy of newer therapies has also highlighted the need to use new diagnostic methods to better assess the progression of the disease and to ensure optimal treatment.

At the Multiple Sclerosis Center, we are focused on treating patients based on the latest scientifically proven methods for assessing the progression of MS.

Assessing the function and structure of the nervous system is important for evaluating the disease, and methods are needed that can help predict the further course of the disease as early as possible.

Optical coherence tomography can help diagnose MS earlier.

Multiple sclerosis is characterized by the breakdown of nerve cells and nerve cell extensions in the central nervous system (CNS). Therefore, optic neuritis is a common symptom.

The optic nerve is part of the central nervous system and is often affected as an initial symptom (optic neuritis) in the manifestation of MS or over the years in the course of the disease.

During the course of the disease, up to 70% of all MS patients develop optic neuritis. This leads to visual impairments and, in the worst case, to loss of vision. With OCT, these changes can be detected early and treated more effectively.

According to new research studies, OCT is also becoming established as a useful addition to traditional MRI and evoked potentials for better diagnosing the progression of MS.

Privacy
Thank you for visiting www.bmg-swiss.ch, the website of Bellevue Medical Group AG in Switzerland. We use technologies from partners (3) to provide our services. These include cookies and third-party tools to process some of your personal data. These technologies are not strictly necessary for the use of the website, but they do enable us to provide a better service and to interact more closely with you. You can adjust or withdraw your consent at any time.
Vendors (non IAB) (3 Vendors)
Google Ireland Limited, Ireland


Google Tag Manager (USA)
Purpose: Initiating, controlling and maintenance of further services
rocessing operations: Collection of connection data and data of your web browser; analysis for advancement of the service
Joint controller: Google LLC, Amphitheatre Parkway, Mountain View, CA 94043, USA
Legal basis of processing: voluntary, revocable consent at any time
Consequences of not consenting: No immediate impact on the website’s function
Legal basis of data transfer to the US: Data will be transmitted to the United States on the basis of your consent according to Art. 49 (1) (a) in conjunction with Art. 6 (1) (a) GDPR. The United States have not adopted data protection standards in conformity with EU requirements. In particular US intelligence agencies will be able to access your data without informing you hand without you and without you being able to take legal action. For this reason, the European Court of Justice has issued a judgment by which it invalidated the previous adequacy decision.

Google LLC, USA

Purpose: Failure analysis, statistical analysis of our website
rocessing operations: Collection of connection data, of data of your web browser and data of accessed content; execution of analysis software and storing of data on your terminal device, anonymization of collected data; analysis of anonymous data in the form of statistics
Storage period: Data on your device for up to two years.
Joint controller: Google LLC, Amphitheatre Parkway, Mountain View, CA 94043, USA
Legal basis of processing: voluntary, revocable consent at any time
Consequences of not consenting: No immediate impact on the website’s function, but limited possibilities of further development and failure analysis
Legal basis of data transfer to the US: Data will be transmitted to the United States on the basis of your consent according to Art. 49 (1) (a) in conjunction with Art. 6 (1) (a) GDPR. The United States have not adopted data protection standards in conformity with EU requirements. In particular US intelligence agencies will be able to access your data without informing you hand without you and without you being able to take legal action. For this reason, the European Court of Justice has issued a judgment by which it invalidated the previous adequacy decision.

Meta Platforms Ireland Ltd., Ireland

Purpose: Provision of Instagram services
rocessing operations: Collection of connection data, of data of your web browser and data of accessed content; placing of advertising cookies by Facebook; processing of collected data by Facebook
Storage period: Data on your device for up to two years
Joint controller: Meta Platforms Ireland Ltd., 4 Grand Canal Square, Grand Canal Harbour, Dublin 2, Ireland
Legal basis of processing: voluntary, revocable consent at any time
Consequences of not consenting: The Instagram service will not be made available.
Legal basis for the transmission of data to the USA:The Facebook group will transmit your personal data to the United States. Data will be transmitted to the United States on the basis of your consent according to Art. 49 (1) (a) in conjunction with Art. 6 (1) (a) GDPR. The United States have not adopted data protection standards in conformity with EU requirements. In particular US intelligence agencies will be able to access your data without informing you hand without you and without you being able to take legal action. For this reason, the European Court of Justice has issued a judgment by which it invalidated the previous adequacy decision.

asd as asd